Replies to post #41102 on Humanigen Inc (HGENQ)

[Newtg]

Chatter from another board would indicate trial is still going, was recently updated and participation has gone from 7 to 24.

[cowtown jay]

Newtg, I can't help but notice that the link you provided indicates there was an update on Nov 30th, which was the date of your post.

"COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial; C-SMART study Arm 4: Effect of Lenzilumab in cancer patients with severe COVID-19 infection.

Up to date
(Last updated: 30/11/2023)"

https://www.anzctr.org.au/TrialSearch.aspx#&&conditionCode=&dateOfRegistrationFrom=&interventionDescription=&interventionCodeOperator=OR&primarySponsorType=&gender=&distance=&postcode=&pageSize=20&ageGroup=&recruitmentCountryOperator=OR&recruitmentRegion=ðicsReview=&countryOfRecruitment=®istry=&searchTxt=Lenzilumab&studyType=&allocationToIntervention=&dateOfRegistrationTo=&recruitmentStatus=&interventionCode=&healthCondition=&healthyVolunteers=&page=1&conditionCategory=&fundingSource=&trialStartDateTo=&trialStartDateFrom=&phase=


But the trial review indicates:

Recruitment status Withdrawn
Reason for early stopping/withdrawal Lack of funding/staff/facilities
Participant recruitment difficulties

However, in checking the NIH National Library of Medicine site, I see the status of the trial is "Completed," and that actual enrollment was 441 participants.

https://clinicaltrials.gov/study/NCT04534725

I've looked at the few other boards I have access to, and don't see anything about this. I assume, therefore, that this info was provided on an "invite only" board.

Wherever it came from, could you share this post there, and see if the posters can provide some guidance in this regard? I can't figure it out. What I see looks contradictory.

Thank you!